In 2024, Gomatam et al. (Gomatam et al. 2024) presented a ML‐based QSAR approach for the informed prediction of PARP‐1 activity, an important target in the treatment of breast cancer, the generated results and insights having the potential to guide medicinal chemists in the design of novel inhibitors for this target. This evidence concerns the gene PARP1 and breast cancer.